Lv1
18 积分 2022-10-11 加入
Case Report: CAR-T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantation
2个月前
已完结
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia
2个月前
已完结
CD34-selected stem cell boost was an effective treatment for refractory poor hematopoietic reconstitution after haploidentical hematopoietic stem cell transplantation
2个月前
已完结
Efficacy and Safety of CD34+ Stem Cell Boost for Delayed Hematopoietic Recovery After BCMA Directed CAR T-cell Therapy
2个月前
已完结
Allogeneic CD34+ Selected Hematopoietic Stem Cell Boost Following CAR T-cell Therapy in a Patient with Prolonged Cytopenia and Active Infection
2个月前
已完结
Successful allogeneic CD34+ hematopoietic stem cell boost for prolonged cytopenias following CAR T-cell therapy in B-cell acute lymphoblastic leukemia. On behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
2个月前
已完结
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells
6个月前
已完结
The genomic landscape of acute myeloid leukemia: Redefining classifications, ontogeny, and therapeutic strategies
6个月前
已关闭
Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
6个月前
已完结
Targeting the BATF family in cancer: Tumor-intrinsic signaling and immune microenvironment reprogramming
7个月前
已完结
皖公网安备34019202002308
